How big is the Thailand Diabetes Drugs And Devices Market?

The Thailand Diabetes Drugs And Devices Market size is expected to reach USD 0.28 billion in 2024 and grow at a CAGR of greater than 5.02% to reach USD 0.35 billion by 2029. Read More

What is the current Thailand Diabetes Drugs And Devices Market size?

In 2024, the Thailand Diabetes Drugs And Devices Market size is expected to reach USD 0.28 billion. Read More

Who are the key players in Thailand Diabetes Drugs And Devices Market?

Medtronics, Roche, NovoNordisk, Sanofi and Omnipod are the major companies operating in the Thailand Diabetes Drugs And Devices Market. Read More

What years does this Thailand Diabetes Drugs And Devices Market cover, and what was the market size in 2023?

In 2023, the Thailand Diabetes Drugs And Devices Market size was estimated at USD 0.27 billion. The report covers the Thailand Diabetes Drugs And Devices Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Thailand Diabetes Drugs And Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Thailand Diabetes Drugs And Devices Market Share

Statistics for the 2023 & 2024 Thailand Diabetes Drugs And Devices market share, created by Mordor Intelligence™ Industry Reports. Thailand Diabetes Drugs And Devices share report includes a market forecast to 029) and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Thailand Diabetes Drugs And Devices Industry

Novo Nordisk partnered with Abbott Diabetes Care, which may also assist to enable insulin statistics to be shared between Novo Nordisk-connected insulin pens and digital fitness equipment well suited to the FreeStyle Libre portfolio of products.